Home  >  Products  >  MCC (mutated in colorectal cancers ) Blocking Peptide (the C terminal of MCC)(100ug)
MCC (mutated in colorectal cancers ) Blocking Peptide (the C terminal of MCC)(100ug)

MCC (mutated in colorectal cancers ) Blocking Peptide (the C terminal of MCC)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MCC Antibody (ARP63047_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63047
Size: 100ug
Weight: 91kDa
Gene: 4163
Format: Lyophilized powder
Target: This gene is a candidate colorectal tumor suppressor gene that is thought to negatively regulate cell cycle progression. The orthologous gene in the mouse expresses a phosphoprotein associated with the plasma membrane and membrane organelles, and overexpression of the mouse protein inhibits entry into S phase. Multiple transcript variants encoding different isoforms have been found for this gene.
Alternative names: DKFZp762O1615; FLJ38893; FLJ46755; MCC1
See Full Product Listings >